Theravance Biopharma Inc
TBPH | NASDAQ
$17.05
$0 (0.00%)
Sep 22, 2026, 10:35 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 104.31M | 109.78M | 107.46M | 80.33M | 77.21M | 65.27M | 64.38M | 63.19M | 62.02M | 61.51M | 57.42M | 54.51M | 51.27M | 48.57M | 51.35M | 51.64M | 52.39M | 54.25M | 55.31M | 59.1M | 64.16M | 66.25M |
Cost of Revenue | 9.62M | 20.11M | 31.56M | 39.51M | 40.66M | 40.13M | 37.64M | 36.5M | 28.57M | 28.05M | 33.65M | 40.68M | 49.21M | 54.71M | 63.39M | 79.27M | 113.14M | 149.31M | 193.66M | 227.6M | 183.86M | 132.76M |
Gross Profit | 94.69M | 89.67M | 75.9M | 40.82M | 36.54M | 25.14M | 26.74M | 26.69M | 33.44M | 33.47M | 23.78M | 13.82M | 2.05M | -6.14M | -12.05M | -27.63M | -60.76M | -95.06M | -138.35M | -168.5M | -119.7M | -66.51M |
Operating Income | -3.02M | 2.54M | -6.05M | -32.81M | -37.2M | -50.18M | -46.95M | -43.99M | -41.91M | -42.33M | -56.04M | -67.23M | -72.67M | -79.65M | -91.96M | -130.69M | -170.11M | -211.12M | -257.78M | -278.11M | -301.11M | -309.17M |
Interest Income | 7.15M | 8.61M | 6.54M | 7.44M | 4.72M | 4.39M | 4.88M | 5.82M | 6.2M | 7.57M | 9.12M | 7.27M | 8.24M | 8.18M | 5.2M | 5.54M | 2.78M | 1.51M | 1.51M | 1.97M | 3.08M | 2.98M |
Pretax Income | 58.92M | 136.92M | 129.25M | 47.24M | 40.08M | -48.35M | -44.61M | -40.69M | -38.22M | -37.19M | -48.48M | -57.72M | -65.65M | -74.25M | -92.29M | -135.7M | -176.09M | -205.49M | -245.2M | -237.18M | -254.82M | -265.49M |
Net Income | 53.81M | 114.54M | 105.9M | 29.34M | 13.03M | -58.33M | -56.42M | -49.4M | -45.65M | -44.77M | -55.19M | -57.05M | 868.54M | 875.99M | 872.13M | 850.46M | -101.48M | -145.69M | -199.43M | -225.83M | -264.16M | -274.64M |
Selling & General & Admin | 51.75M | 37.58M | 19.86M | 18.5M | 18.5M | 18.5M | 18.5M | 15.85M | 31.08M | 50.36M | 69.55M | 70.43M | 71.47M | 68.41M | 67.07M | 71.86M | 76.88M | 86.59M | 68.75M | 77.29M | 83.49M | 82.34M |
Research & Development | 25.62M | 31.39M | 37.02M | 39.43M | 40.59M | 40.05M | 37.57M | 37.19M | 35.8M | 37.21M | 44.57M | 52.87M | 56.52M | 61.61M | 70.07M | 85.91M | 121.43M | 157.31M | 201.55M | 237.87M | 258.2M | 268.25M |
Other Expenses | 20.34M | 18.16M | 25.08M | 15.7M | 14.65M | 16.77M | 17.62M | 17.64M | 8.48M | -11.78M | -34.31M | -42.25M | -53.26M | -56.52M | -57.24M | -54.7M | -88.95M | -127.85M | -150.86M | -205.54M | -160.28M | -107.92M |
Operating Expenses | 97.71M | 87.13M | 81.95M | 73.63M | 73.74M | 75.32M | 73.69M | 70.68M | 75.36M | 75.8M | 79.81M | 81.05M | 74.72M | 73.5M | 79.91M | 103.07M | 109.35M | 116.05M | 119.44M | 109.61M | 181.41M | 242.66M |
Interest Expense | 1.16M | 1.82M | 2.46M | 2.52M | 2.58M | 2.56M | 2.55M | 2.53M | 2.51M | 2.43M | 2.35M | 2.28M | 3.21M | 4.78M | 6.37M | 17.48M | 18.07M | 27.55M | 37.52M | 37.54M | 46.97M | 46.75M |
Selling & Marketing Expenses | n/a | n/a | n/a | 4.3M | 4.3M | 4.3M | 4.3M | 5.1M | 5.1M | 5.1M | 5.1M | 8M | 8M | 8M | 8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 107.33M | 107.24M | 113.51M | 113.14M | 114.4M | 115.44M | 111.33M | 107.18M | 103.93M | 103.84M | 113.46M | 121.73M | 123.93M | 128.21M | 143.3M | 182.34M | 222.49M | 265.37M | 313.1M | 337.2M | 365.27M | 375.43M |
Income Tax Expense | 5.11M | 22.37M | 23.35M | 17.9M | 27.05M | 9.98M | 11.8M | 8.71M | 7.43M | 7.58M | 6.71M | 3.22M | 2.36M | 910K | 1.04M | 1.19M | 687K | 902K | 605K | 9.25M | 9.34M | 9.16M |
Shares Outstanding (Basic) | 51.67M | 51.28M | 50.87M | 50.52M | 50.18M | 49.71M | 49.31M | 49.04M | 48.75M | 48.28M | 49.42M | 52.36M | 56.68M | 62.93M | 67.4M | 75.52M | 76.27M | 75.25M | 73.62M | 73.57M | 65.67M | 64.49M |
Shares Outstanding (Diluted) | 51.67M | 51.28M | 53.05M | 51.91M | 50.73M | 49.71M | 49.31M | 49.04M | 48.75M | 48.28M | 49.42M | 52.36M | 56.68M | 62.93M | 67.4M | 75.52M | 76.27M | 75.25M | 73.96M | 73.57M | 65.67M | 64.49M |
EPS (Basic) | 1.06 | 2.26 | 2.09 | 0.58 | 0.25 | -1.18 | -1.15 | -1.01 | -0.92 | -0.86 | -0.97 | -1.01 | 11.30 | 11.47 | 11.48 | 11.25 | -1.37 | -2.06 | -2.96 | -3.44 | -4.12 | -4.32 |
EPS (Diluted) | 1.01 | 2.20 | 2.03 | 0.57 | 0.24 | -1.18 | -1.15 | -1.01 | -0.92 | -0.86 | -0.97 | -1.01 | 11.30 | 11.47 | 11.48 | 11.26 | -1.36 | -2.05 | -2.95 | -3.44 | -4.12 | -4.32 |
EBITDA | 62.83M | 141.89M | 134.45M | 51.69M | 44.75M | -41.86M | -38.12M | -36.72M | -33.51M | -34.91M | -48.14M | -55.32M | -62.58M | -68.02M | -72.36M | -96.52M | -133.86M | -153.87M | -209.29M | -246.89M | -256.64M | -266.68M |
EBIT | 60.08M | 138.74M | 131.71M | 49.76M | 42.8M | -43.82M | -40.1M | -38.4M | -36.1M | -38.3M | -51.86M | -58.97M | -65.69M | -70.83M | -75.39M | -99.48M | -137.64M | -158.11M | -214.11M | -252.8M | -262.93M | -273.82M |
Depreciation & Amortization | 2.75M | 3.16M | 2.74M | 1.93M | 1.95M | 1.96M | 1.98M | 1.68M | 2.59M | 3.39M | 3.72M | 3.65M | 3.11M | 2.81M | 3.04M | 2.97M | 3.77M | 4.24M | 4.81M | 5.91M | 6.29M | 7.14M |
Add to Watchlist
Select watchlists to add or remove TBPH